Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?

被引:42
|
作者
Nguyen, T. N. [1 ,2 ,3 ,4 ]
Cumming, R. G. [4 ]
Hilmer, S. N. [1 ,2 ,3 ]
机构
[1] Univ Sydney, Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW 2006, Australia
[2] Univ Sydney, Royal N Shore Hosp, Dept Aged Care, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sydney Med Sch, Kolling Inst Med Res, Sydney, NSW 2006, Australia
[4] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia
关键词
atrial fibrillation; frailty; anticoagulant; anti-arrhythmic; stroke; bleeding; ANTICOAGULATION THERAPY; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; MAJOR HEMORRHAGE; HEART-FAILURE; HIGH-RISK; WARFARIN; STROKE; DIGOXIN; IMPACT;
D O I
10.1111/imj.12912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundFrailty is common in patients with atrial fibrillation and may impact on antithrombotic and anti-arrhythmic treatment. AimTo describe differences in clinical characteristics, prescription of antithrombotic and anti-arrhythmic medications and incidence of haemorrhage and stroke, between frail and non-frail older inpatients. MethodsProspective observational study in patients aged 65years with atrial fibrillation admitted to a teaching hospital in Sydney, Australia. Frailty was assessed using the Reported Edmonton Frail Scale, stroke risk with CHA2DS2-VASc score and bleeding risk with HAS-BLED score. Participants were followed after 6months for haemorrhages and strokes. ResultsWe recruited 302 patients (mean age 84.7 7.1years, 53.3% frail, 50% female, mean CHA2DS2-VASc 4.61 +/- 1.44, mean HAS-BLED 2.97 +/- 1.04). Frail participants were older and had more co-morbidities and higher risk of stroke but not haemorrhage. Upon discharge, 55.7% participants were prescribed with anticoagulants (49.3% frail, 62.6% non-frail, P = 0.02). Thirty-three per cent received antiplatelets only and 11.1% no antithrombotics, with no difference by frailty status. For anti-arrhythmics, 52.6% received rate-control drugs only, 11.8% rhythm-control drugs only and 13.5% both and 22.1% were not prescribed either, with no difference by frailty status. On univariate logistic regression, frailty decreased the likelihood of anticoagulant prescription (odds ratio (OR) 0.58, 95%CI 0.36-0.93), but this was not significant on multivariate analysis (OR 0.66, 95%CI 0.40-1.11). After 6months, overall incidence of ischaemic stroke was 2.1%, and in patients taking anticoagulants, incidence of major/severe bleeding was 6.3%, with no significant difference between frailty groups. ConclusionsFrailty status had little impact on antithrombotic prescription and no impact on anti-arrhythmic prescription.
引用
收藏
页码:86 / 95
页数:10
相关论文
共 47 条
  • [1] Antiplatelet responses in frail and non-frail older inpatients with atrial fibrillation
    Tu Nguyen
    Morel-Kopp, Marie-Christine
    Ward, Christopher
    Cumming, Robert
    Hilmer, Sarah
    AUSTRALASIAN JOURNAL ON AGEING, 2014, 33 : 58 - 58
  • [2] Platelet aggregability in frail and non-frail older inpatients with atrial fibrillation
    Nguyen, T.
    Ward, C.
    Morel-Kopp, M-C
    Cumming, R.
    Hilmer, S.
    AUSTRALASIAN JOURNAL ON AGEING, 2013, 32 : 43 - 43
  • [3] RESPONSE TO ANTIPLATELET DRUGS IN FRAIL AND NON-FRAIL OLDER INPATIENTS WITH ATRIAL FIBRILLATION
    Nguyen, T. N.
    Morel-Kopp, M.
    Ward, C.
    Pepperell, D.
    Cumming, R. G.
    Hilmer, S.
    GERONTOLOGIST, 2014, 54 : 92 - 93
  • [4] DIRECT ORAL ANTICOAGULANTS VERSUS WARFARIN FOR ATRIAL FIBRILLATION IN FRAIL AND NON-FRAIL PATIENTS
    Ozaki, Masatomo
    Tasaka, Hiroshi
    Hata, Reo
    Yoshino, Mituru
    Ohashi, Noriyuki
    Kadota, Kazushige
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 286 - 286
  • [5] Coagulation changes in frail and robust older inpatients with atrial fibrillation
    Nguyen, T.
    Ward, C.
    Morel-Kopp, M-C
    Cumming, R.
    Hilmer, S.
    AUSTRALASIAN JOURNAL ON AGEING, 2013, 32 : 44 - 44
  • [6] Clinical Outcomes of Endovascular versus Surgical Revascularization in Frail and Non-Frail Older Adults
    Ko, Darae
    Park, Chan Mi
    Evans, Peter
    Pande, Ashvin
    Hamburg, Naomi
    Kim, Dae Hyun
    CIRCULATION, 2024, 150
  • [7] Differences in trunk accelerometry between frail and non-frail elderly persons in functional tasks
    Galán-Mercant A.
    Cuesta-Vargas A.I.
    BMC Research Notes, 7 (1)
  • [8] Do Adverse Drug Reactions Vary Between Frail and Non-Frail Hospitalized Older Adults?
    Cheong, S.
    Ong, E. H.
    Goh, W.
    Karim, S. B. Abdul
    See, L.
    Chong, E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S90 - S90
  • [9] A Comparison of Human Plasma Glycoproteome between Pre-Frail and Non-Frail Older Adults
    Shamsi, K.
    Pierce, A.
    Halade, D.
    Richardson, A.
    Espinoza, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S184 - S184
  • [10] ASSOCIATIONS BETWEEN PHYSICAL AND COGNITIVE DIMENSIONS AFTER FITNESS TRAINING IN FRAIL AND NON-FRAIL OLDER ADULTS
    Bobeuf, F.
    Langlois, F.
    Vu, M.
    Kergoat, M.
    Bherer, L.
    GERONTOLOGIST, 2011, 51 : 70 - 71